Stephan Madersbacher
Donauspital, Sigmund Freud University Vienna, Kaiser-Franz-Josef-Spital
Papers
5
Total Citations
320
H-Index
5
About
Stephan Madersbacher is a leading urologic surgeon and researcher whose work spans the surgical and minimally invasive management of urologic cancers and benign prostatic hyperplasia (BPH). His most influential contribution is a landmark study on positive surgical margins after nephron-sparing surgery (225 citations), which provided critical insights into optimizing oncologic outcomes in kidney cancer surgery. Madersbacher has also been at the forefront of evaluating novel, minimally invasive treatments for LUTS/BPH, authoring a comprehensive review that defines target populations for emerging therapies (44 citations). His expertise extends to bladder cancer, where he contributed to the ICUD–SIU International Consultation on Bladder Cancer 2018 update on urinary diversion (27 citations), and to prostate cancer surgery, where his prospective analysis of catheter removal timing after robot-assisted radical prostatectomy (16 citations) has helped refine postoperative protocols. Through these contributions, Madersbacher has shaped evidence-based practice in urology, balancing oncologic rigor with quality-of-life considerations.
Research Focus
Key Achievements
Top Papers
- 1Positive Surgical Margins After Nephron-Sparing Surgery225 citations · 2011
- 2
- 3
- 4
- 5